← Back to headlines
Abbott Laboratories Expected to Benefit from Nutrition Segment Recovery
Abbott Laboratories (ABT) is anticipated to see positive performance driven by a recovery in its nutrition segment.
23 Feb, 20:41 — 23 Feb, 20:41
Sources
Showing 1 of 1 sources
